Skip to content

Author

Hai-Ying Ji

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A Nanodelivery Platform Harnessing Synthetic Lethality and Efferocytosis Inhibition for Synergistically Enhanced Immunotherapy of Triple-Negative Breast Cancer.

Triple-negative breast cancer (TNBC), defined by the absence of specific therapeutic targets, shows poor clinical benefit and readily develops chemoresistance, underscoring the need for therapies that couple precise tumor cell killing with robust antitumor immunity. Drug-induced immunogenic cell death (ICD) is a promis...

Hua-Wei Liu, Sheng-Ming Wu, Han Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.